Joignez-vous à David Gourde, Inf. et CRE, pour une discussion sur comment vous pouvez aider vos patients à libérer leurs poumons avec un traitement non-pharmacologique.
Cette session a été établie en partenariat avec Alliance Pharma.
Votre conférencier : David Gourde, Inf. B. Sc. CRE Intervenant pivot-réseau en maladies pulmonaires chroniques
Nouveautés Loi 31 – Enfin! Mais comment faire mieux avec nos patients en santé respiratoire?
L’ajout récent des prises en charge pour l’asthme et la MPOC dans les actes de la Loi 31 est une opportunité intéressante et rentable d’améliorer la santé respiratoire des patients. Ce webinaire vous permettra de mettre à jour vos connaissances en santé respiratoire, d’obtenir des outils pratiques afin de réaliser ces actes dans vos pharmacies et d’apprivoiser leur facturation. Un événement à ne pas manquer!
Join Professor Omar Usmani and Dr. John Pritchard as they review the environmental impact of inhaled medications. Tune in to discover how to develop patient centric strategies to reduce the impact of inhalers on the climate.
This conversation will cover:
Climate change and carbon impact of pressurised Metered Dose Inhalers (pMDIs)
Join Dr. Douglas Mack and Dr. Mariam Hanna as they discuss the importance of asthma control in today’s world, as well as the shift to virtual appointments including tools and tips to optimize virtual asthma assessments. Please see a recording of the session below.
Join Isabelle LeClerc in this 30-minute webinar as she discusses the importance of airway clearance techniques and oscillating positive expiratory pressure (OPEP) devices, including during the COVID-19 pandemic. Please see a recording of the session below.
More consistent dose delivery was achieved with the breath actuated technology rather than breath enhanced. Delivering medication only when the patient inhales would result in more stable therapy if I:E ratio was to change with disease< progression or if the patient took breaks to talk during treatment.
Presented at the British Thoracic Society December 2018.
Having a child with asthma can be stressful for parents, especially for financially strapped ones struggling to pay for an arsenal of puffers and pills for their child’s treatment. Because of this, those healthcare professionals who recommend spacer chambers may suggest one of many lower-cost versions that are available on the market today. But focusing only on cost may be putting a child’s health at risk.
More consistent dose delivery was achieved with the breath actuated technology rather than breath enhanced. Delivering medication only when the patient inhales would result in more stable therapy if I:E ratio was to change with disease< progression or if the patient took breaks to talk during treatment.
New information regarding the efficiency and effectiveness of different oscillating positive expiratory pressure devices was presented at CHEST 2017 in Toronto, Canada.
Manage asthma during wildfires by monitoring air quality, indoor cleanliness, limiting outdoor exposure, wearing masks, consulting healthcare providers, and optimizing medication with AeroChamber VHC* and AeroChamber 2Go*.
Valved holding chambers are widely prescribed to assist patients receiving inhaled medications by avoiding losses caused by imperfect coordination of inhalation and actuation and also to reduce oropharyngeal deposition.
Regardless of whether using a solution based formulation (like Qvar) or a suspension formulation (Flovent), the use of a valved holding chamber reduced the amount of medication deposited in the mouth (oropharynx) and increased the potential for lung delivery
This study can be used to help demonstrate the value of using a valved holding chamber for both solution and suspension formulated metered dose inhalers and for all patient populations, including adults
Manage asthma during wildfires by monitoring air quality, indoor cleanliness, limiting outdoor exposure, wearing masks, consulting healthcare providers, and optimizing medication with AeroChamber VHC* and AeroChamber 2Go*.
The FRI deposition profiles highlighted significant differences between the VHCs on test, with intrathoracic delivery for the AeroChamber Plus* Flow-Vu* VHC system being almost double that of the other two VHC systems and being similar to the MDI alone with perfect coordination
Join Dr. Sacha Bhinder, HBSc, MD, FRCPC, for a review of inhaled delivery device products that are available in Canada, and how to foster customized care when choosing the most appropriate device for your patient.
From a UK perspective, BUD/F delivered via an MDI + VHC offers an economic benefit for the treatment of patients with mild asthma. Further analysis is required to determine if there would be any quality-adjusted life-year (QALY) effects based on the chosen intervention.
